BROWN GREGORY B
Insider CIK 1373585 · AQST Director · CLBS Director · CBM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | A Award deriv | 2026-06-10 | 2026-06-12 | 50,500 | — | $0 | 50,500 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2026-01-09 | 2026-01-13 | 30,456 | — | $0 | 95,659 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2025-06-11 | 2025-06-12 | 42,000 | $3.41 | $143.2K | 42,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2025-01-09 | 2025-01-13 | 15,789 | — | $0 | 65,203 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2024-06-20 | 2024-06-21 | 38,000 | — | $0 | 38,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2024-01-09 | 2024-01-11 | 19,480 | — | $0 | 49,414 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-06-21 | 2023-06-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2023-01-09 | 2023-01-11 | 20,000 | — | $0 | 29,934 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-06-22 | 2022-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2022-01-10 | 2022-01-12 | 65,430 | — | $0 | 149,040 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2021-06-15 | 2021-06-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2021-01-11 | 2021-01-12 | 37,735 | — | $0 | 83,610 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2020-06-16 | 2020-06-18 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2020-01-13 | 2020-01-14 | 18,292 | $3.28 | $60.0K | 45,875 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 360 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 2,766 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 1,980 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 2,766 | $40.06 | $110.8K | 9,015 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 1,980 | $53.70 | $106.3K | 6,249 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 360 | $44.23 | $15.9K | 4,269 | SEC↗ |
| CBM CAMBREX CORP | S Sale | 2019-12-04 | 2019-12-05 | 9,015 | $60.00 | $540.9K | 0 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-06-13 | 2019-06-17 | 13,350 | — | $0 | 13,350 | SEC↗ |
| CBM CAMBREX CORP | A Award deriv | 2019-04-24 | 2019-04-25 | 2,766 | — | $0 | 2,766 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2019-04-24 | 2019-04-25 | 2,247 | — | $0 | 3,909 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2019-01-14 | 2019-01-16 | 12,121 | $4.95 | $60.0K | 27,583 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2019-01-08 | 2019-01-10 | 8,747 | — | $0 | 15,462 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-07-24 | 2018-07-26 | 26,700 | — | $0 | 26,700 | SEC↗ |
| CBM CAMBREX CORP | A Award deriv | 2018-04-26 | 2018-04-30 | 1,980 | — | $0 | 1,980 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2018-04-26 | 2018-04-30 | 1,397 | — | $0 | 1,662 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award deriv | 2018-01-08 | 2018-01-10 | 8,747 | — | $0 | 8,747 | SEC↗ |
| CBM CAMBREX CORP | A Award deriv | 2017-10-31 | 2017-11-02 | 360 | — | $0 | 360 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2017-10-31 | 2017-11-02 | 265 | — | $0 | 265 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award | 2017-05-16 | 2017-05-18 | 2,565 | — | $0 | 6,715 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award deriv | 2017-01-09 | 2017-01-31 | 2,750 | — | $0 | 2,750 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award | 2017-01-09 | 2017-01-31 | 1,650 | — | $0 | 4,150 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award deriv | 2016-10-10 | 2016-10-12 | 4,150 | — | $0 | 4,150 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award | 2016-10-10 | 2016-10-12 | 2,500 | — | $0 | 2,500 | SEC↗ |